Skip to main content
Premium Trial:

Request an Annual Quote

LA Investment Firm Helping Chinese Genomics Firm Land US Pharma Deals

NEW YORK, May 28 (GenomeWeb News) - NewCap Partners, a Los Angeles-based boutique investment-banking company, is helping Shanghai Genomics forge contract research alliances with US drug makers, according to a report on Forbes.com today.

 

Shanghai Genomics, based in Shanghai, China,offers the following services, according to its website: siRNA design and synthesis; protein-protein interaction screening; and gene-expression studies using Q-PCR or IHC. The firm employs 70 person people.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.